Epizyme Inc (NASDAQ:EPZM) stock underwent a rollercoaster ride on Wednesday, eventually finishing positive at $12.35, nearly 11% increase.
Just in front of its option deadline, Celgene Corporation (NASDAQ:CELG) has re-upped on an existing research and discovery collaboration with Epizyme Inc (NASDAQ:EPZM), a developer …
Advanced Micro Devices, Inc. (NASDAQ:AMD) increased 3.